BH
Therapeutic Areas
Nephronomics Pipeline
| Drug | Indication | Phase |
|---|---|---|
| Nephronomics Atlas Discovery | Cardio-Kidney-Metabolic (CKM) Disease Subtyping & Target ID | Discovery |
Leadership Team at Nephronomics
JW
Jan Walter, MBA
Founder & Acting CEO
DK
Deniz Kural, PhD
Founder & CSO
JS
James Sietstra
Founder & Board Member
MS
Michael Strömberg, PhD
Head of Data Science and Bioinformatics
EG
Eric Green, MD, PhD
Scientific Advisor
FM
Franklin Maddux, MD
Scientific Advisor
NT
Navdeep Tangri, MD, PhD
Scientific Advisor